Results 1 to 10 of about 11,883 (171)

Rebound hypertension following prolonged oxymetazoline use: a signal-generating case report [PDF]

open access: yesTherapeutic Advances in Drug Safety
Topical nasal decongestants containing α-adrenergic agonists such as oxymetazoline are widely available over the counter and are generally perceived as safe when used as directed. Manufacturer instructions typically recommend limited dosing frequency and
Domenico Merante
doaj   +2 more sources

Efficacy of Oxymetazoline 0.1% in Acquired Blepharoptosis: A Systematic Review and Meta-Analysis of Randomized Clinical Trials [PDF]

open access: yesClinical Ophthalmology
Razan O Bawazir,1,2 Jumanah T Qedair,1,2 Ziad M Bukhari,3 Orjwan S Badghaish,1,2 Rahaf A Hubayni,1,2 Ali S Alsudais,1,2 Mohammed F Qutub2,3 1College of Medicine, King Saud bin Abdulaziz University for Health Sciences, Jeddah, Saudi Arabia; 2King Abdullah
Bawazir RO   +6 more
doaj   +2 more sources

The Latest Advances in Rosacea Treatment: A Systematic Review [PDF]

open access: yesPharmaceuticals
Background: Rosacea is a chronic inflammatory dermatosis characterized by vascular dysregulation, immune dysfunction, neurovascular alterations, and microbial involvement.
Anastazja Andrusiewicz   +5 more
doaj   +2 more sources

Intranasal Oxymetazoline and Xylometazoline Use in Patients With Deviated Nasal Septum: A Cross‐Sectional Telephone Survey [PDF]

open access: yesOTO Open
Objective To assess the pattern of oxymetazoline and xylometazoline (OXM) use in patients with deviated nasal septum (DNS). Study design A retrospective Computer‐Assisted Telephone Interviewing survey.
Marcin Masalski   +4 more
doaj   +2 more sources

Part 1 - imidazolines and the changing face of nasal decongestants [PDF]

open access: yesFrontiers in Pharmacology
Imidazolines are sympathomimetic drugs used to treat a range of conditions including nasal congestion, ocular disorders, and hypertension. Imidazolines were discovered over 150 years ago.
Rebecca J. Stinson, Laura R. Sadofsky
doaj   +2 more sources

An Oxymetazoline-Based Hemostatic Solution Used with MTA for Pulpal Therapy: A Retrospective Study [PDF]

open access: yesChildren
Background/Objectives: The purpose of this study is to assess whether the addition of an oxymetazoline (OXY) hemostatic solution, which can be used to manage pulpal bleeding, maintains higher MTA survivability than pulpotomies treated with FS.
Robert S. Jones   +3 more
doaj   +2 more sources

Tissue Biocompatibility and Antimicrobial Properties of Sympathomimetic Nasal Solutions for Potential Use in Dental Pulpal Management [PDF]

open access: yesClinical and Experimental Dental Research
Objectives Sympathomimetic nasal solutions (SNS), containing oxymetazoline or phenylephrine, may be used directly onto dental pulp tissue and initiate hemostasis via activation of alpha‐receptors that innervate arteriole smooth muscles.
Robert S. Jones   +3 more
doaj   +2 more sources

Part II – imidazolines and rhinitis medicamentosa: how can we tackle the rebound dilemma? [PDF]

open access: yesFrontiers in Pharmacology
Rhinitis medicamentosa is the state of chronic congestion experienced from the prolonged or excessive use of nasal vasoconstrictors, typically used in the treatment of nasal congestion.
Rebecca J. Stinson, Laura R. Sadofsky
doaj   +2 more sources

Oxymetazoline hydrochloride ophthalmic solution, 0.1%, boosts the effects of botulinum toxin on blepharospasm: a case series

open access: yesJournal of Medical Case Reports, 2022
Background Oxymetazoline hydrochloride ophthalmic solution (0.1%) is a medication used to treat blepharoptosis. Patients who suffer from blepharoptosis have low-lying eyelids that can hinder their vision.
Jonathan Sung   +3 more
doaj   +1 more source

Premedication Methods in Nasal Endoscopy: A Prospective, Randomized, Double-Blind Study [PDF]

open access: yesClinical and Experimental Otorhinolaryngology, 2017
Objectives To identify the optimal pharmacological method of preparing patients for nasal endoscopy. Methods Twenty healthy volunteers were enrolled in this prospective, randomized, double-blind study.
Mehmet İlhan Şahin   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy